## ASML: ASML Holding N.V. - New York Re - XLK: Technology

### Executive Summary

No thesis match: MRS_10 0.9% below STRENGTH zone (3.0-6.0%); PEG 1.92 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1061.32)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. ASML's China Dealings Stir Tension After Military Link Report - ASML Holding (NASDAQ:ASML)**
- Source: Benzinga | 20251209T091033 | Neutral | Relevance: 99%
-  ASML is under renewed scrutiny due to reports linking its Chinese customers to the military, even as strong demand for its chipmaking tools supports its long-term growth. The company maintains full compliance with export laws despite allegations of selling parts to Chinese military suppliers. China remains ASML's largest market, and analysts project significant revenue growth by 2030, driven by AI infrastructure and the company's near-monopoly on EUV technology.

**2. Investor Optimism Around AI Boosted ASML (ASML) in Q3**
- Source: Insider Monkey | 20251209T074400 | Bullish | Relevance: 98%
-  Polen Capital's "Polen International Growth Strategy" highlighted ASML Holding N.V. as a strong performer in Q3 2025, with ASML's stock seeing significant gains due to investor optimism surrounding AI. The company's essential role in producing advanced semiconductor equipment for AI-related chips contributed to its positive performance.

**3. ASML: Growth Outlook Strong, Upside Limited At This Multiple (NASDAQ:ASML)**
- Source: Seeking Alpha | 20251211T141018 | Neutral | Relevance: 98%
-  ASML has seen significant growth in 2025, with its shares rallying over 60% year-to-date and its market cap exceeding $400 billion. Despite strong fundamentals and above-market margins, the company's valuation at 39x FY2025 earnings suggests limited upside. The author rates ASML as a Hold with a $1,176 price target, indicating that its current price already reflects its quality and promising outlook.

**4. ASML Stock Price Forecast - ASML at $1,104: EUV Monopoly and AI Boom vs. 39x Earnings Valuation**
- Source: TradingNEWS | 20251211T171018 | Somewhat-Bullish | Relevance: 98%
-  ASML Holding NV maintains its position as a long-term AI lithography heavyweight, benefiting from its monopoly in Extreme Ultraviolet (EUV) lithography critical for AI chip manufacturing. Despite cyclical demand, ASML's robust financial performance, including a 29-30% net income margin and solid order book, supports its growth trajectory towards €44B–€60B in revenue by 2030. However, the stock's current valuation at 39x forward earnings suggests limited short-term upside, leading to a "Hold" recommendation for new entries above $1,050.

**5. New Buy Rating for ASML Holding NV (0QB8), the Technology Giant**
- Source: The Globe and Mail | 20251211T071018 | Bullish | Relevance: 97%
-  Citi analyst Andrew Gardiner maintained a Buy rating on ASML Holding NV with a price target of €1,200.00. Goldman Sachs also issued a Buy rating, while Barclays maintained a Hold rating for the company, which has a market cap of €367.9B and a P/E ratio of 39.74. Gardiner has a strong track record in covering the Technology sector.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-03 | B of A Securiti | $1331 | $1092 | +22% |
| 2025-12-01 | JP Morgan | $1275 | $1175 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-03 | B of A Securiti | main | Buy |
| 2025-12-01 | JP Morgan | main | Overweight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 8.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- JPMORGAN CHASE & CO: 1.5% (+170.0%)
- Fisher Asset Managem: 1.1% (+2.5%)
- Capital World Invest: 1.1% (-4.1%)
- Capital Internationa: 1.0% (+17.3%)
- State Farm Mutual Au: 0.7% (0.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.92 elevated, pricing in significant growth expectations. Forward P/E 43.3x stretched relative to 5% growth. Quality metrics strong (ROE 54%, ROA 16%, margin 29%). Analyst sentiment positive (2 raises, avg +15%). Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $435.8B |
| Beta | 1.35 |
| 52W Range | $578.51 - $1141.72 |
| Short Interest | 0.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.92 |
| Forward P/E | 43.3 |
| Current P/E | 45.4 |
| YoY Growth | 4.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 2.0% to 0.9% (-1.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.1pp (needs >3.0% for momentum thesis). MRS_5 at 0.7% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (6.19), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.92% (CS: 48) | Neutral |
| RSI_14 | 62.3 | Neutral |
| MACD Histogram | 6.19 | Bullish |
| vs SMA20 | 1.062x | Above |
| vs SMA50 | 1.081x | Above |
| vs SMA200 | 1.369x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1122.84
- **Stop Loss:** $1061.32 (5.5% risk)
- **Target:** $1184.36 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 22
- **Position Value:** $24,702.48
- **Portfolio %:** 24.70%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-28 (Est: $7.53)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.37 | $5.49 | +2.1% |
| 2025Q2 | $5.25 | $5.90 | +12.4% |
| 2025Q1 | $5.79 | $6.00 | +3.7% |
| 2024Q4 | $6.73 | $6.84 | +1.6% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*